🔗 Share this article

The prestigious award in Physiology or Medicine was granted for transformative findings that illuminate how the immune system targets dangerous pathogens while sparing the body's own cells.

A trio of renowned researchers—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this honor.

The work uncovered specialized "security guards" within the immune system that remove rogue immune cells that could harming the organism.

The findings are now paving the way for innovative therapies for autoimmune diseases and cancer.

The winners will divide a prize fund worth 11 million Swedish kronor.

Crucial Discoveries

"The work has been essential for comprehending how the body's defenses operates and the reason we don't all suffer from severe self-attack conditions," stated the chair of the Nobel Committee.

This team's research address a fundamental question: In what way does the defense system protect us from countless infections while keeping our healthy cells unharmed?

The immune system employs white blood cells that scan for indicators of infection, including viruses and germs it has never encountered.

These defenders utilize sensors—known as receptors—that are produced randomly in countless combinations.

That provides the defense network the capacity to combat a broad range of threats, but the unpredictability of the process inevitably creates immune cells that may target the body.

Security Guards of the Body

Scientists earlier understood that a portion of these harmful defense cells were destroyed in the immune organ—the site where white blood cells develop.

This year's award honors the discovery of regulatory T-cells—described as the immune system's "security guards"—which patrol the system to disarm other immune cells that assault the healthy cells.

We know that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

A prize committee stated, "The findings have established a novel area of investigation and accelerated the development of new treatments, for example for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the body from fighting the growth, so studies are focused on reducing their quantity.

In self-attack disorders, trials are testing boosting regulatory T-cells so the body is not under attack. A similar method could also be useful in reducing the risks of transplanted organ failure.

Innovative Experiments

Professor Sakaguchi, from a Japanese institution, performed experiments on rodents that had their thymus removed, leading to self-attack conditions.

The researcher demonstrated that injecting immune cells from other mice could prevent the illness—suggesting there was a system for blocking immune cells from harming the body.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were investigating an inherited immune disorder in mice and humans that led to the discovery of a gene vital for how T-regs function.

"The groundbreaking research has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the healthy cells," said a leading biological science specialist.

"This research is a remarkable illustration of how fundamental biological study can have broad consequences for public health."